{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:31:23Z","timestamp":1793143883447,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"vor","delay-in-days":81,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.nmd.2017.11.004","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T15:45:21Z","timestamp":1511451921000},"page":"197-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":621,"title":["Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics"],"prefix":"10.1016","volume":"28","author":[{"given":"Richard S.","family":"Finkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar H.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita K.","family":"Simonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Schroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janbernd","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan T.","family":"Iannaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas O.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunhilde","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Main","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena S.","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Quijano-Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Hurst","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sejersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.nmd.2017.11.004_bib0010","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/0883073807305788","article-title":"Consensus statement for standard of care in spinal muscular atrophy","volume":"22","author":"Wang","year":"2007","journal-title":"J Child Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2017.11.004_bib0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/mus.23904","article-title":"SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy","volume":"49","author":"Kissel","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2017.11.004_bib0020","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2017.11.004_bib0025","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.nmd.2017.02.014","article-title":"218th ENMC International Workshop: revisiting the consensus on standards of care in SMA Naarden, The Netherlands, 19\u201321 February 2016","volume":"27","author":"Finkel","year":"2017","journal-title":"Neuromusc Disord"},{"issue":"3","key":"10.1016\/j.nmd.2017.11.004_bib0030","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/088307389400900321","article-title":"Pulmonary function in spinal muscular atrophy","volume":"9","author":"Samaha","year":"1994","journal-title":"J Child Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.nmd.2017.11.004_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thoraxjnl-2012-201964","article-title":"British Thoracic Society guideline for respiratory management of children with neuromuscular weakness","volume":"67","author":"Hull","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.nmd.2017.11.004_bib0040","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1097\/PCC.0b013e3182388ad1","article-title":"Spinal muscular atrophy type 1: are proactive respiratory interventions associated with longer survival?","volume":"13","author":"Lemoine","year":"2012","journal-title":"Pediatr Critical Care Med"},{"key":"10.1016\/j.nmd.2017.11.004_bib0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ppul.10110","article-title":"Spinal muscular atrophy type 1: management and outcomes","volume":"34","author":"Bach","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.nmd.2017.11.004_bib0050","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/PHM.0b013e31804a8505","article-title":"Long-term survival in Werdnig Hoffmann disease","volume":"86","author":"Bach","year":"2007","journal-title":"Am J Phys Med Rehabil"},{"issue":"Suppl. 4","key":"10.1016\/j.nmd.2017.11.004_bib0055","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.1542\/peds.2008-2952K","article-title":"Special considerations in the respiratory management of spinal muscular atrophy","author":"Schroth","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.nmd.2017.11.004_bib0060","doi-asserted-by":"crossref","first-page":"e1509","DOI":"10.1542\/peds.2012-2278","article-title":"Survival of patients with spinal muscular atrophy type 1","volume":"131","author":"Gregoretti","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.nmd.2017.11.004_bib0065","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.paed.2009.08.017","article-title":"Respiratory problems in spinal muscular atrophy in the paediatric age group","volume":"34","author":"Chiarini Testa","year":"2009","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.nmd.2017.11.004_bib0070","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/01.PHM.0000083669.22483.04","article-title":"Prevention of pectus excavatum for children with spinal muscular atrophy type 1","volume":"82","author":"Bach","year":"2003","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.nmd.2017.11.004_bib0075","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/thx.2004.037424","article-title":"Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia","volume":"60","author":"Ward","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.nmd.2017.11.004_bib0080","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/PHM.0b013e31802ef774","article-title":"Noninvasive ventilation in children with spinal muscular atrophy types 1 and 2","volume":"86","author":"Petrone","year":"2007","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.nmd.2017.11.004_bib0085","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1212\/WNL.0b013e318271f7e4","article-title":"Prospective cohort study of spinal muscular atrophy types 2 and 3","volume":"79","author":"Kaufmann","year":"2012","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.nmd.2017.11.004_bib0090","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2012-201964","article-title":"British Thoracic Society guideline for respiratory management of children with neuromuscular weakness","volume":"67","author":"Hull","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.nmd.2017.11.004_bib0095","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.nmd.2015.09.009","article-title":"1st Italian SMA Family Association Consensus Meeting: management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30\u201331 January 2015","volume":"25","author":"Sansone","year":"2015","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.nmd.2017.11.004_bib0100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ejpn.2012.01.004","article-title":"Abnormal fatty acid metabolism in spinal muscular atrophy may predispose to perioperative risks","volume":"16","author":"Zolkipli","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.nmd.2017.11.004_bib0105","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1212\/01.WNL.0000086813.59722.72","article-title":"Patients with severe muscle wasting are prone to develop hypoglycemia during fasting","volume":"61","author":"Orngreen","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2017.11.004_bib0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/1531-8249(199903)45:3<337::AID-ANA9>3.0.CO;2-U","article-title":"Abnormal fatty acid metabolism in childhood spinal muscular atrophy","volume":"45","author":"Crawford","year":"1999","journal-title":"Ann Neurol"},{"issue":"Suppl. 4","key":"10.1016\/j.nmd.2017.11.004_bib0115","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1007\/s00586-014-3335-6","article-title":"Non-invasive positive pressure ventilation to facilitate the post-operative respiratory outcome of spine surgery in neuromuscular children","volume":"23","author":"Khirani","year":"2014","journal-title":"Eur Spine J"},{"key":"10.1016\/j.nmd.2017.11.004_bib0120","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PHM.0b013e318232883a","article-title":"Spinal muscular atrophy type 1: avoidance of hospitalization by respiratory muscle support","volume":"90","author":"Ottonello","year":"2011","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.nmd.2017.11.004_bib0125","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1378\/chest.117.4.1100","article-title":"Spinal muscular atrophy type 1: a noninvasive respiratory management approach","volume":"117","author":"Bach","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.nmd.2017.11.004_bib0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.PHM.0000151941.97266.96","article-title":"Mechanical insufflation-exsufflation improves outcomes for neuromuscular disease patients with respiratory tract infections","volume":"84","author":"Vianello","year":"2005","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.nmd.2017.11.004_bib0135","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1542\/peds.110.2.e24","article-title":"Respiratory support in spinal muscular atrophy type I: a survey of physician practices and attitudes","volume":"110","author":"Hardart","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.nmd.2017.11.004_bib0140","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1440-1754.2007.01197.x","article-title":"Physician attitudes towards ventilatory support for spinal muscular atrophy type 1 in Australasia","volume":"43","author":"Geevasinga","year":"2007","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.nmd.2017.11.004_bib0145","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1097\/CCM.0b013e3181a00578","article-title":"Experiencing the pediatric intensive care unit: perspective from parents of children with severe antecedent disabilities","volume":"37","author":"Graham","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.nmd.2017.11.004_bib0150","first-page":"147","article-title":"Parental role in the Intensive Care Unit for children affected by Werdnig Hoffmann disease","volume":"62","author":"Ottonello","year":"2010","journal-title":"Minerva Pediatr"},{"key":"10.1016\/j.nmd.2017.11.004_bib0155","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1177\/0883073813503988","article-title":"Nutritional practices at a glance: spinal muscular atrophy type I nutrition survey findings","volume":"29","author":"Davis","year":"2014","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2017.11.004_bib0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0887-8994(94)00100-G","article-title":"Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)","volume":"12","author":"Tein","year":"1995","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.nmd.2017.11.004_bib0165","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(95)91439-0","article-title":"Hypoglycaemia in spinal muscular atrophy","volume":"346","author":"Bruce","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2017.11.004_bib0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-0034-1395348","article-title":"Cardiac function in types II and III spinal muscular atrophy: should we change standards of care?","volume":"46","author":"Bianco","year":"2015","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nmd.2017.11.004_bib0175","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/WNP.0b013e31829dde84","article-title":"Preservation of motor evoked potentials under anesthesia in children with spinal muscular atrophy type II undergoing spinal deformity surgery","volume":"30","author":"Norton","year":"2013","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.nmd.2017.11.004_bib0180","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1460-9592.2009.03055.x","article-title":"Anesthesia and perioperative medical management of children with spinal muscular atrophy","volume":"19","author":"Graham","year":"2009","journal-title":"Paediatr Anaesth"},{"issue":"7","key":"10.1016\/j.nmd.2017.11.004_bib0185","article-title":"Drug treatment for spinal muscular atrophy types II and III","author":"Bosboom","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.nmd.2017.11.004_bib0190","article-title":"Drug treatment for spinal muscular atrophy type I","author":"Wadman","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nmd.2017.11.004_bib0195","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/WNL.59.4.609","article-title":"Pilot trial of albuterol in spinal muscular atrophy","volume":"59","author":"Kinali","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2017.11.004_bib0200","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.nmd.2008.05.004","article-title":"Daily salbutamol in young patients with SMA type II","volume":"18","author":"Pane","year":"2008","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.nmd.2017.11.004_bib0205","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy","volume":"86","author":"Chiriboga","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2017.11.004_bib0210","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.nmd.2017.11.004_bib0215","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1474-4422(17)30085-6","article-title":"Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind placebo controlled phase 2 trial","volume":"16","author":"Bertini","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2017.11.004_bib0220","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2017.11.004_bib0225","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","article-title":"The survival motor neuron protein in spinal muscular atrophy","volume":"6","author":"Coovert","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2017.11.004_bib0230","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0002-9440(10)65578-2","article-title":"Cell-specific survival motor neuron gene expression during human development of the central nervous system: implications for the pathogenesis of spinal muscular atrophy","volume":"153","author":"Tizzano","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nmd.2017.11.004_bib0235","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0092-8674(00)81632-3","article-title":"A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing","volume":"95","author":"Pellizzoni","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.nmd.2017.11.004_bib0240","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molmed.2012.11.002","article-title":"Spinal muscular atrophy: going beyond the motor neuron","volume":"19","author":"Hamilton","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.nmd.2017.11.004_bib0245","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/joa.12083","article-title":"Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?","volume":"224","author":"Shababi","year":"2014","journal-title":"J Anat"},{"key":"10.1016\/j.nmd.2017.11.004_bib0250","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1093\/hmg\/ddq329","article-title":"Cardiac defects contribute to the pathology of spinal muscular atrophy models","volume":"19","author":"Shababi","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2017.11.004_bib0255","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1093\/hmg\/ddq147","article-title":"Spinal muscular atrophy: mechanisms and therapeutic strategies","volume":"19","author":"Lorson","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2017.11.004_bib0260","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/jmg.2008.057950","article-title":"Congenital heart disease is a feature of severe infantile spinal muscular atrophy","volume":"45","author":"Rudnik-Schoneborn","year":"2008","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2017.11.004_bib0265","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/PHM.0b013e31804b1d66","article-title":"Medical considerations of long-term survival of Werdnig-Hoffmann disease","volume":"86","author":"Bach","year":"2007","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.nmd.2017.11.004_bib0270","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00000441-200612000-00009","article-title":"Cardiac involvement in Kugelberg-Welander disease: a case report and review","volume":"332","author":"Takahashi","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.nmd.2017.11.004_bib0275","first-page":"611","article-title":"[Cardiac involvement in Kugelberg-Welander disease. A prospective study of 8 cases]","volume":"89","author":"Elkohen","year":"1996","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.nmd.2017.11.004_bib0280","first-page":"175","article-title":"Cardiac involvement in patients with spinal muscular atrophies","volume":"30","author":"Palladino","year":"2011","journal-title":"Acta Myol"},{"key":"10.1016\/j.nmd.2017.11.004_bib0285","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.23582","article-title":"Glucose metabolism and pancreatic defects in spinal muscular atrophy","volume":"72","author":"Bowerman","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2017.11.004_bib0290","article-title":"Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-III","volume":"12","author":"Kolbel","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2017.11.004_bib0295","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1002\/jnr.22106","article-title":"Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy","volume":"87","author":"Acsadi","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nmd.2017.11.004_bib0300","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1242\/dmm.021766","article-title":"Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy","volume":"9","author":"Xu","year":"2016","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.nmd.2017.11.004_bib0305","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1053\/apmr.2003.50243","article-title":"Threats to \u201cinformed\u201d advance directives for the severely physically challenged?","volume":"84","author":"Bach","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.nmd.2017.11.004_bib0310","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0387-7604(99)00127-8","article-title":"Ethical attitudes of Japanese physicians regarding life-sustaining treatment for children with severe neurological disabilities","volume":"22","author":"Sakakihara","year":"2000","journal-title":"Brain Dev"},{"key":"10.1016\/j.nmd.2017.11.004_bib0315","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/adc.2009.166512","article-title":"Implementation of \u201cthe consensus statement for the standard of care in spinal muscular atrophy\u201d when applied to infants with severe type 1 SMA in the UK","volume":"95","author":"Roper","year":"2010","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nmd.2017.11.004_bib0320","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.neurol.2012.07.020","article-title":"Recommendations for the diagnosis and management of typical childhood spinal muscular atrophy","volume":"168","author":"Cuisset","year":"2012","journal-title":"Rev Neurol (Paris)"},{"issue":"Suppl. 1","key":"10.1016\/j.nmd.2017.11.004_bib0325","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/j.prrv.2006.04.200","article-title":"Spinal muscular atrophy type 1: what are the ethics and practicality of respiratory support?","volume":"7","author":"Mitchell","year":"2006","journal-title":"Paediatr Resp Reviews"},{"key":"10.1016\/j.nmd.2017.11.004_bib0330","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1017\/S1478951514000042","article-title":"Palliative care in children with spinal muscular atrophy type I: what do they need?","volume":"13","author":"Garcia-Salido","year":"2015","journal-title":"Palliat Support Car"},{"key":"10.1016\/j.nmd.2017.11.004_bib0335","series-title":"Death's dominion: ethics at the end of life. Facing death series","author":"Woods","year":"2007"},{"key":"10.1016\/j.nmd.2017.11.004_bib0340","doi-asserted-by":"crossref","first-page":"e548","DOI":"10.1542\/peds.2004-0668","article-title":"Spinal muscular atrophy: survival pattern and functional status","volume":"114","author":"Chung","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.nmd.2017.11.004_bib0345","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jpeds.2012.05.067","article-title":"Pathophysiological insights derived by natural history and motor function of spinal muscular atrophy","volume":"162","author":"Farrar","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.nmd.2017.11.004_bib0350","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jpeds.2016.04.062","article-title":"Parents' experiences and wishes at end of life in children with spinal muscular atrophy types I and II","volume":"175","author":"Lovgren","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.nmd.2017.11.004_bib0355","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0883073816671236","article-title":"Spinal muscular atrophy type I: is it ethical to standardize supportive care intervention in clinical trials?","volume":"32","author":"Finkel","year":"2017","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2017.11.004_bib0360","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1542\/peds.2004-1260","article-title":"Classifying recommendations for clinical practice guidelines","volume":"114","author":"American Academy of Pediatrics Steering Committee on Quality I, Management","year":"2004","journal-title":"Pediatrics"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896617312907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896617312907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:07:05Z","timestamp":1760774825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896617312907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0960896617312907"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2017.11.004","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}